Most rotator-cuff tears are degenerative, atraumatic, and more prevalent with age. Nonoperative treatment, including physical ...

According to a surprising report courtesy of the Chicago Tribune’s Brad Biggs, between then and now, the 27-year-old OL ...

WWE Hall of Famer Kevin Nash has been dealing with a herniated disc and shoulder injury, and he recently opened up about his health. On the latest episode of his Kliq This podcast, Nash said that he ...

WWE Hall of Famer Kevin Nash has been open about his health, and in recent weeks, he has noted that he is dealing with a disc ...

Korean 15-Step Stem Cell Scalp Treatment incorporates medical grade products containing plant-based ingredients alongside human stem cell culture extract, known for effective hair loss and hair fall ...

One recently approved therapy combines gene editing and a stem cell treatment for sickle cell disease. Yet amid the hope for revolutionary treatments, rogue clinics have promoted cures that were ...

Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus Therapeutics has secured US Food and Drug Administration (FDA) approval for ...

IN A GROUNDBREAKING medical achievement, a 25-year-old woman with Type 1 diabetes (T1D) in China has successfully undergone a stem-cell therapy that enabled her to produce her own insulin, reducing ...

Department of Medical Life Sciences, Department of Medical Sciences (Graduate School), and Catholic Photomedicine Research Institute, College of Medicine, The Catholic University of Korea, 222 ...

An advanced therapy ... tears in the knee saves many patients from having to undergo surgery. The tear is glued with a special tissue adhesive (fibrin glue) and the body's own stem cells, allowing ...

Three people with severely impaired vision who received stem-cell transplants ... trials in March to assess the treatment’s efficacy. Several other iPS-cell-based trials are under way globally ...

Regarding safety, treatment was both safe and well-tolerated by patients with relapsing-remitting MS. A phase 2 trial evaluating Hope Biosciences’ adipose-derived autologous mesenchymal stem cell ...